7096 — StemCell Institute Cashflow Statement
0.000.00%
Last trade - 00:00- ¥11bn
- ¥8bn
- ¥3bn
- 73
- 24
- 12
- 26
Annual cashflow statement for StemCell Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 91.4 | 213 | 279 | 441 | 566 |
| Depreciation | |||||
| Non-Cash Items | 2.39 | 17.8 | 40 | -16.8 | -120 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 112 | 142 | -324 | -210 | -106 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 239 | 469 | 99.7 | 335 | 468 |
| Capital Expenditures | -403 | -204 | -59.9 | -202 | -575 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -117 | 609 | -225 | -610 | 316 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -520 | 404 | -285 | -812 | -259 |
| Financing Cash Flow Items | — | — | -0.001 | — | -0.002 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 644 | -0.869 | -1.33 | 147 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -281 | 1,518 | -186 | -478 | 355 |